NCT01328535View on ClinicalTrials.gov

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 22, 2013

Study Completion Date

July 11, 2018

Conditions

Recurrent MelanomaStage IV Melanoma

Interventions

DRUG

temozolomide

Given PO

OTHER

flow cytometry

Correlative studies

OTHER

staining method

Correlative studies

PROCEDURE

biopsy

Optional correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER